Maryland State Retirement & Pension System’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-10,936
Closed -$251K – 1374
2025
Q2
$251K Hold
10,936
– – 0.01% 1355
2025
Q1
$317K Sell
10,936
-1,694
-13% -$54.1K 0.01% 1201
2024
Q4
$469K Sell
12,630
-191
-1% -$8.73K 0.01% 1104
2024
Q3
$622K Sell
12,821
-478
-4% -$21K 0.01% 934
2024
Q2
$532K Sell
13,299
-282
-2% -$11.7K 0.01% 1101
2024
Q1
$549K Hold
13,581
– – 0.01% 1050
2023
Q4
$840K Sell
13,581
-455
-3% -$23.9K 0.02% 784
2023
Q3
$646K Sell
14,036
-634
-4% -$34.6K 0.01% 871
2023
Q2
$843K Sell
14,670
-511
-3% -$22.7K 0.02% 725
2023
Q1
$569K Sell
15,181
-337
-2% -$11K 0.01% 954
2022
Q4
$435K Sell
15,518
-116
-0.7% -$3.37K 0.01% 1087
2022
Q3
$439K Buy
15,634
+398
+3% +$13K 0.04% 361
2022
Q2
$530K Buy
15,236
+461
+3% +$16.5K 0.02% 906
2022
Q1
$530K Buy
14,775
+233
+2% +$6.61K 0.01% 1035
2021
Q4
$339K Hold
14,542
– – 0.01% 1312
2021
Q3
$281K Buy
+14,542
New +$285K 0.01% 1398

Other funds holding AMPH

Maryland State Retirement & Pension System's AMPH Position: Q3 2025 in Review

Maryland State Retirement & Pension System sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2025, closing a stake of 10,936 shares — an estimated $251K sold.

Maryland State Retirement & Pension System first reported a position in AMPH in Q3 2021 and held it in 16 quarters. The position peaked at $843K in Q2 2023. 243 funds tracked by Wall St. Rank hold AMPH as of Q3 2025.

  • Maryland State Retirement & Pension System reported no remaining Amphastar Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 10,936 Amphastar Pharmaceuticals shares in Q3 2025, an estimated $251K.
  • Maryland State Retirement & Pension System first reported a position in Amphastar Pharmaceuticals in Q3 2021 and held it in 16 quarters.
  • Maryland State Retirement & Pension System's Amphastar Pharmaceuticals position peaked at $843K in Q2 2023.
  • 243 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2025.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2025, filed 29 Oct 2025.